down arrow

Fredun Pharma

Part of MojoOne Strategy
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE194R01017
  • NSEID:
  • BSEID: 539730
  • View on BSE
INR
1,789.00
-7.6 (-0.42%)
BSENSE

Feb 10

BSE+NSE Vol: 16.31 k

Access older stock analysis version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationNine Monthly Results
Results Snapshot
Figures in Cr
Consolidate Nine Monthly Results
Dec'25
Dec'24
Net Sales
426.08
167.41
Other Operating Income
0.00
0.00
Total Operating income
426.08
167.41
Raw Material Cost
310.43
125.01
Purchase of Finished goods
0.00
0.00
(Increase) / Decrease In Stocks
-9.60
-1.23
Employee Cost
24.08
9.70
Power Cost
0.00
0.00
Manufacturing Expenses
11.02
4.59
Selling and Distribution Expenses
0.00
0.00
Other Expenses
24.49
12.09
Total Expenditure (Excl Depreciation)
360.42
150.16
Operating Profit (PBDIT) excl Other Income
65.66
17.25
Other Income
0.00
0.00
Operating Profit (PBDIT)
65.66
17.25
Interest
24.81
8.15
Exceptional Items
0.00
0.00
Gross Profit (PBDT)
40.85
9.10
Depreciation
5.09
1.84
Profit Before Tax
35.75
7.26
Tax
9.07
1.26
Provisions and contingencies
0.00
0.00
Profit After Tax
26.68
6.00
Extraordinary Items
0.00
0.00
Prior Period Expenses
0.00
0.00
Other Adjustments
0.00
0.00
Net Profit
26.68
6.00
Share in Profit of Associates
0.00
0.00
Minority Interest
0.00
0.00
Other related items
0.00
0.00
Consolidated Net Profit
26.68
6.00
Equity Capital
4.72
4.72
Face Value
10.0
10.0
Reserves
0.00
0.00
Diluted Earnings per share
22.19
12.71
Operating Profit Margin (Excl OI)
15.41%
10.3%
Gross Profit Margin
9.59%
5.44%
PAT Margin
6.26%
3.58%
Public Share Holdings (%)
51.07%
51.07%
Pledged Promotor Holding (%)
0.0%
0.0%
Nine Monthly Analysis Highlights
stock-summary

Net Sales

YoY Growth in nine months ended Dec 2025 is 47.73% vs 24.81% in Dec 2024

stock-summary

Standalone Net Profit

YoY Growth in nine months ended Dec 2025 is 96.50% vs 30.02% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in nine months ended Dec 2025 is 74.33% vs 35.89% in Dec 2024

stock-summary

Interest

YoY Growth in nine months ended Dec 2025 is 74.47% vs 53.23% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in nine months ended Dec 2025 has improved from Dec 2024

Compare Nine Monthly Results Of Fredun Pharma With
Markets Mojo
Figures in Cr
Consolidate Nine Monthly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
426.08
0
426.08
Other Operating Income
0.00
0.00
0.00
Total Operating income
426.08
0
426.08
Raw Material Cost
310.43
0
310.43
Purchase of Finished goods
0.00
0
0.00
(Increase) / Decrease In Stocks
-9.60
0
-9.60
Employee Cost
24.08
0
24.08
Power Cost
0.00
0
0.00
Manufacturing Expenses
11.02
0
11.02
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
24.49
0.00
24.49
Total Expenditure (Excl Depreciation)
360.42
0
360.42
Operating Profit (PBDIT) excl Other Income
65.66
0.00
65.66
Other Income
0.00
0
0.00
Operating Profit (PBDIT)
65.66
0
65.66
Interest
24.81
0
24.81
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
40.85
0
40.85
Depreciation
5.09
0
5.09
Profit Before Tax
35.75
0
35.75
Tax
9.07
0
9.07
Provisions and contingencies
0.00
0
0.00
Profit After Tax
26.68
0
26.68
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
26.68
0
26.68
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
26.68
0
26.68
Equity Capital
4.72
0
4.72
Face Value
10.00
0
0.00
Reserves
0.00
0
0.00
Gross Profit Margin
9.59%
0.00%
0.00
9.59%
PAT Margin
6.26%
0.00%
0.00
6.26%
Public Share Holdings (%)
51.07%
0%
51.07
51.07%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 422.92 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 47.73% vs 24.81% in Dec 2024

Nine Monthly - Standalone Net Profit
Standalone Net Profit 26.98 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 96.50% vs 30.02% in Dec 2024

Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 65.67 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 74.33% vs 35.89% in Dec 2024

Nine Monthly - Interest
Interest 24.81 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 74.47% vs 53.23% in Dec 2024

Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 15.41%
in Dec 2025

Figures in %
stock-summary

YoY Growth in nine months ended Dec 2025 has improved from Dec 2024

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Download on App Store
Get it on Google Play
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."